In addition to any issues of treatment compliance, and maximised corticosteroids (inhaled or oral) and beta agonist,<unk>  treatment also involves for type 1 additional subcutaneous injections of beta2 agonist and inhalation of long acting beta-adrenoceptor agonist, whilst type 2 needs allergen avoidance and self-management approaches. Since catastrophic attacks are unpredictable in type 2, patients may display identification of the issue, such as a MedicAlert bracelet, and carry an epinephrine autoinjector.
Brittle asthma
Thunderstorm asthma
Yokkaichi asthma
Reactive airway disease
Cardiac asthma
Asthma
Mineral dust airway disease
Occupational asthma